Literature DB >> 27294246

Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be premature.

Ivo G Schoots1.   

Abstract

Entities:  

Year:  2016        PMID： 27294246      PMCID： PMC4885902          DOI： 10.21037/atm.2016.03.53

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  8 in total

1.  In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?

Authors:  Simpa S Salami; Eran Ben-Levi; Oksana Yaskiv; Laura Ryniker; Baris Turkbey; Louis R Kavoussi; Robert Villani; Ardeshir R Rastinehad
Journal:  BJU Int       Date:  2015-04       Impact factor: 5.588

2.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

3.  Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Authors:  Christian Arsov; Robert Rabenalt; Dirk Blondin; Michael Quentin; Andreas Hiester; Erhard Godehardt; Helmut E Gabbert; Nikolaus Becker; Gerald Antoch; Peter Albers; Lars Schimmöller
Journal:  Eur Urol       Date:  2015-06-23       Impact factor: 20.096

Review 4.  Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

Authors:  Ivo G Schoots; Monique J Roobol; Daan Nieboer; Chris H Bangma; Ewout W Steyerberg; M G Myriam Hunink
Journal:  Eur Urol       Date:  2014-12-03       Impact factor: 20.096

5.  [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].

Authors:  T Durmus; C Stephan; M Grigoryev; G Diederichs; M Saleh; T Slowinski; A Maxeiner; A Thomas; T Fischer
Journal:  Rofo       Date:  2013-02-18

6.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.

Authors:  Geoffrey A Sonn; Edward Chang; Shyam Natarajan; Daniel J Margolis; Malu Macairan; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Robert E Reiter; Leonard S Marks
Journal:  Eur Urol       Date:  2013-03-17       Impact factor: 20.096

7.  Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.

Authors:  Neil Mendhiratta; Xiaosong Meng; Andrew B Rosenkrantz; James S Wysock; Michael Fenstermaker; Richard Huang; Fang-Ming Deng; Jonathan Melamed; Ming Zhou; William C Huang; Herbert Lepor; Samir S Taneja
Journal:  Urology       Date:  2015-08-31       Impact factor: 2.649

8.  Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.

Authors:  Srinivas Vourganti; Ardeshir Rastinehad; Nitin Yerram; Jeffrey Nix; Dmitry Volkin; An Hoang; Baris Turkbey; Gopal N Gupta; Jochen Kruecker; W Marston Linehan; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450
  8 in total
  10 in total

1.  Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer.

Authors:  Amr Mahran; Kirtishri Mishra; Laura Bukavina; Fredrick Schumacher; Anna Quian; Christina Buzzy; Carvell T Nguyen; Vikas Gulani; Lee E Ponsky
Journal:  Int Urol Nephrol       Date:  2019-05-02       Impact factor: 2.370

2.  Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens.

Authors:  Arnoud W Postema; Maudy C W Gayet; Ruud J G van Sloun; Rogier R Wildeboer; Christophe K Mannaerts; C Dilara Savci-Heijink; Stefan G Schalk; Amir Kajtazovic; Henk van der Poel; Peter F A Mulders; Harrie P Beerlage; Massimo Mischi; Hessel Wijkstra
Journal:  World J Urol       Date:  2020-02-20       Impact factor: 4.226

3.  68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results.

Authors:  Chen Liu; Teli Liu; Zhongyi Zhang; Ning Zhang; Peng Du; Yong Yang; Yiqiang Liu; Wei Yu; Nan Li; Michael A Gorin; Steven P Rowe; Hua Zhu; Kun Yan; Zhi Yang
Journal:  J Nucl Med       Date:  2020-02-07       Impact factor: 10.057

Review 4.  Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017.

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2017-05       Impact factor: 2.309

5.  Magnetic resonance imaging-ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?

Authors:  Christopher Antonio Febres-Aldana; Sarah Alghamdi; Thomas A Weppelmann; Emilio Lastarria; Akshay Bhandari; Yumna Omarzai; Robert J Poppiti
Journal:  Urol Ann       Date:  2020-10-15

Review 6.  The current role of prostate multiparametric magnetic resonance imaging.

Authors:  Olivier Rouviere; Paul Cezar Moldovan
Journal:  Asian J Urol       Date:  2018-12-11

7.  Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI.

Authors:  Maudy C W Gayet; Anouk A M A van der Aa; Harrie P Beerlage; Bart Ph Schrier; Maaike Gielens; Roel Heesakkers; Gerrit J Jager; Peter F A Mulders; Hessel Wijkstra
Journal:  Prostate Cancer       Date:  2020-04-03

8.  Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis.

Authors:  Liang Zhen; Xiaoqiang Liu; Chen Yegang; Yang Yongjiao; Xu Yawei; Kang Jiaqi; Wang Xianhao; Song Yuxuan; Hu Rui; Zhang Wei; Ou Ningjing
Journal:  BMC Cancer       Date:  2019-12-23       Impact factor: 4.430

9.  Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies.

Authors:  Brage Krüger-Stokke; Helena Bertilsson; Sverre Langørgen; Torill Anita Eidhammer Sjøbakk; Tone Frost Bathen; Kirsten Margrete Selnæs
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

10.  Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study.

Authors:  Joseph M Norris; Lucy A M Simmons; Abi Kanthabalan; Alex Freeman; Neil McCartan; Caroline M Moore; Shonit Punwani; Hayley C Whitaker; Mark Emberton; Hashim U Ahmed
Journal:  Eur Urol Open Sci       Date:  2021-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.